This is the first in a series of quarterly publications for the Global Health Council looking at drug development, healthcare providers such as hospitals and digital health, payments and patient wellness. This first article looks at the implications of the disease treatments coming out of advanced research and artificial intelligence and the broader shift to digitalisation in healthcare. The next issue will focus on the providers of healthcare.
Tag: Magazine
Magazine article
Corporate venturing continues strong in February
Monthly analysis: February
A shining beacon in the dark
Where do you begin to summarise a year that has been the most challenging on a global scale in living memory?
What 500 Startups sees in emerging ecosystems
Comment from Bedy Yang, managing partner and head of ecosystems, 500vc, and Ee-Ling Lim, regional director for Asia-Pacific
How to bypass the usual operational pitfalls of CVC
Comment from Carol Strobel, operating partner, Redpoint eVentures, Brazil
How to make the right long-term bets on innovation at a time of rapid change
Comment from Vanessa Colella, chief innovation officer, Citi, and David Kidder, co-founder and CEO, Bionic
Best practices in corporate venture capital
Comment from Amy Burr, managing director, JetBlue Technology Ventures
Innovation and digitisation mean healthcare is at a tipping point
Feature: artificial intelligence driving disease prevention, digital health enables personalised medicine, investment takes off
Industrials survive the pandemic
Sector analysis: Industrial
Spac attack shows innovation frenzy
March 2021 issue editorial by James Mawson, editor in chief, Global Corporate Venturing